TrialHaematologica2015

Rituximab maintenance for patients with aggressive B-cell lymphoma in first remission: results of the randomized NHL13 trial.

Ulrich Jaeger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.